Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$693M |
| 2 |
Constellation Brands
STZ
|
+$368M |
| 3 |
Tesla
TSLA
|
+$332M |
| 4 |
NVIDIA
NVDA
|
+$300M |
| 5 |
Booking.com
BKNG
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$821M |
| 2 |
Netflix
NFLX
|
+$777M |
| 3 |
AbbVie
ABBV
|
+$583M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$477M |
| 5 |
FedEx
FDX
|
+$456M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Consumer Discretionary | 17.72% |
| 3 | Financials | 13.25% |
| 4 | Healthcare | 11.94% |
| 5 | Communication Services | 11.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Norwegian Cruise Line
NCLH
$9.74B
| $62.7M | 0.06% |
1,326,341
-76,496
| -5% | -$4.03M |
|
227
Alliant Energy
LNT
$19.1B
| $62.3M | 0.06% |
1,472,243
-506,022
| -26% | -$20.8M |
|
228
Sprouts Farmers Market
SFM
$7.31B
| $62.2M | 0.06% |
2,819,867
+571,684
| +25% | +$12.9M |
|
|
XEC
229
DELISTED
CIMAREX ENERGY CO
XEC
| $62.1M | 0.06% |
610,509
-27,837
| -4% | -$2.64M |
|
230
Hyatt Hotels
H
$17.8B
| $61.2M | 0.06% |
792,842
-308,114
| -28% | -$24.5M |
|
231
McCormick & Company Non-Voting
MKC
$13.9B
| $61M | 0.06% |
1,051,134
+130,330
| +14% | +$6.84M |
|
232
Zoetis
ZTS
$32.5B
| $60.9M | 0.06% |
714,701
-797,362
| -53% | -$67.3M |
|
233
Teleflex
TFX
$5.94B
| $60.7M | 0.06% |
+226,337
| New | +$60.7M |
|
234
Wells Fargo
WFC
$263B
| $60.3M | 0.06% |
1,087,612
+428,673
| +65% | +$23M |
|
235
Viatris
VTRS
$20.8B
| $60.3M | 0.06% |
1,667,552
+232,483
| +16% | +$9.12M |
|
|
TGE
236
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
| $59.7M | 0.06% |
2,694,780
+19,694
| +0.7% | +$418K |
|
237
DexCom
DXCM
$28.9B
| $59.3M | 0.06% |
2,499,080
-1,410,956
| -36% | -$29.9M |
|
|
AAMI
238
Acadian Asset Management
AAMI
$2.94B
| $59.3M | 0.06% |
4,158,138
+726,469
| +21% | +$11.1M |
|
239
Ingersoll Rand
IR
$33.9B
| $59.2M | 0.06% |
2,012,670
+20,612
| +1% | +$649K |
|
240
Celanese
CE
$4.77B
| $58.5M | 0.06% |
527,082
-3,006
| -0.6% | -$332K |
|
|
PRAH
241
DELISTED
PRA Health Sciences, Inc.
PRAH
| $58.4M | 0.06% |
625,994
+611,949
| +4,357% | +$52.7M |
|
242
Entergy
ETR
$52.4B
| $58.3M | 0.06% |
1,443,906
+1,034,068
| +252% | +$40.9M |
|
|
HRC
243
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $58.1M | 0.06% |
665,564
+206,487
| +45% | +$18.4M |
|
|
STI
244
DELISTED
SunTrust Banks, Inc.
STI
| $57.8M | 0.06% |
875,551
-253,721
| -22% | -$17.2M |
|
|
EXAS
245
DELISTED
Exact Sciences
EXAS
| $57.8M | 0.06% |
966,260
+4,096
| +0.4% | +$220K |
|
246
CSX Corp
CSX
$94.2B
| $57.1M | 0.06% |
2,684,802
+533,193
| +25% | +$11M |
|
247
Agnico Eagle Mines
AEM
$71.9B
| $56.8M | 0.06% |
1,239,202
-48,469
| -4% | -$2.13M |
|
248
Puma Biotechnology
PBYI
$406M
| $56.3M | 0.05% |
950,998
+465,453
| +96% | +$27M |
|
249
CoStar Group
CSGP
$12.4B
| $56.2M | 0.05% |
1,361,160
+229,260
| +20% | +$8.82M |
|
250
Merck
MRK
$326B
| $56.1M | 0.05% |
969,343
+96,289
| +11% | +$5.43M |
|
Similar funds
Jennison Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Jennison Associates held 740 positions worth $103B, up 2% from $101B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Jennison Associates withdrew a net $3.95B in Q2 2018, closing 87 positions and reducing 296 holdings. Its most notable exit was Great Plains Energy Incorporated, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jennison Associates opened a new position in AstraZeneca worth $677M.
- Jennison Associates's largest Q2 2018 buy was AstraZeneca: 9,637,084 shares worth $677M.
- Jennison Associates added most to Constellation Brands in Q2 2018, an estimated $368M increase.
- Jennison Associates's biggest Q2 2018 reduction was Charter Communications, cutting an estimated $821M.
- Jennison Associates fully exited Great Plains Energy Incorporated in Q2 2018, selling an estimated $152M.
- Jennison Associates's ten largest holdings make up 29% of its $103B portfolio in Q2 2018.
- Jennison Associates opened 89 new positions and closed 87 in Q2 2018.
- Jennison Associates's portfolio value rose 2% quarter-over-quarter to $103B.
Based on Jennison Associates's 13F filing for Q2 2018, filed 2 Aug 2018.